← Back to Patent Explorer
US4902516A Expired / Lapsed US ⏱️ 0.0 years remaining

Binder-free granules with delayed release of the active compound

Assignee: CHEMIE HOLDING AKTIENGESELLSCHAFT ST PETER-STRASSE 25 A-4021 LINZ AUSTRIA
•
Filing: 1988-04-06
•
Granted: 1990-02-20
•
Expires: 2008-04-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Binder-free granules for oral and parenteral administration with delayed release of the active compound, consisting of a pharmaceutical active compound or granules thereof and a coating of 1 to 20% by weight of poly-D(-)-3-hydroxybutyric acid, based on the total weight, and a process for their preparation.

Inventors

  • 👤 Werner Korsatko
  • 👤 Brigitta Korsatko-Wabnegg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 08:02
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5031

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 63 words
Binder-free granules for oral and parenteral administration with delayed release of the active compound consisting of a pharmaceutical active compound or granules thereof and poly-D(-)-3-hydroxybutyric acid having a molecular weight of about 50,000 to about 800,000, wherein the active compound or granules thereof is/are coated with an amount of 1 to 20% by weight of said poly-D(-)-3-hydroxybutyric acid, based on the total weight.
Claim 2
Dependent Claim 63 words
Binder-free granules for oral and parenteral administration with delayed release of the active compound consisting of a pharmaceutical active compound or granules thereof and poly-D(-)-3-hydroxybutyric acid having a molecular weight of about 50,000 to about 800,000, wherein the active compound or granules thereof is/are coated with an amount of 1 to 20% by weight of said poly-D(-)-3-hydroxybutyric acid, based on the total weight.
Claim 3
Dependent Claim 31 words
Binder-free granules as claimed in claim 1, wherein the active compound or granules thereof is/are coated with an amount of 1 to 15% of poly-D(-)-3-hydroxybutyric acid, based on the total weight.
Claim 4
Dependent Claim 31 words
Binder-free granules as claimed in claim 1, wherein the active compound or granules thereof is/are coated with an amount of 3 to 10% of poly-D(-)-3-hydroxybutyric acid, based on the total weight.
Claim 5
Dependent Claim 13 words
Binder-free granules as claimed in claim 1, wherein the active compound is 7-hydroxyethyltheophylline.
Claim 6
Dependent Claim 21 words
Binder-free granules as claimed in claim 1, wherein the molecular weight of the poly-D(-)-3-hydroxybutyric acid used is between 100,000 and 400,000.
Claim 7
Dependent Claim 14 words
Binder-free granules as claimed in claim 1, wherein the active compound is celiprolol hydrochloride.
Claim 8
Dependent Claim 15 words
Binder-free granules as claimed in claim 1, which have been prepared by fluidized bed granulation.
Claim 9
Dependent Claim 14 words
Binder-free granules as claimed in claim 1, wherein the active compound is hexobendine dichloride.
Claim 10
Dependent Claim 13 words
Binder-free granules as claimed in claim 1, wherein the active compound is ibuprofen.
Claim 11
Dependent Claim 13 words
Binder-free granules as claimed in claim 1, wherein the active compound is dichlofenac-Na.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-02-19 1993-08-21 1994-02-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-02-19 1997-08-21 1998-02-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-02-19 2001-08-21 2002-02-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag